General Dentistry News

Dentistry

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nikitakis NG et al. - Taken together, these data support the importance of the constitutive Stat3 signaling for growth and survival of salivary gland cancer cells through the induction of survivin. Inhibition of the oncogenic Stat3-survivin pathway in these cells can be achieved by selective targeting techniques or treatment with the NSAID sulindac and holds promise for the treatment of salivary gland cancer.

Related Articles

Nonsteroidal anti-inflammatory drugs
Cancer, 10/16/09    Relevance Score: 46%

Effect of nonsteroidal anti-inflammatory drug plasters for knee osteoarthritis in Japanese: a randomized controlled trial
Modern Rheumatology, 10/12/09    Relevance Score: 45%

Perioperative Use of Nonsteroidal Anti-Inflammatory Drugs: Results of a UK Regional Audit
Clinical Drug Investigation, 10/15/09    Relevance Score: 44%

Single dose oral sulindac for acute postoperative pain in adults
Cochrane Reviews, 10/09/09    Relevance Score: 44%

Use of Nonsteroidal Antiinflammatory Drugs and Risk of Endometrial Cancer
American Journal of Epidemiology, 11/09/09    Relevance Score: 43%

Today in OMF Pathology...keeping you current

The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation
European Journal of Anaesthesiology, 12/08/09

Intralesional Corticosteroid Injection for Central Giant Cell Granuloma: An Alternative Treatment for Children
Journal of Dentistry for Children, 12/07/09

An Uncommon Focal Epithelial Hyperplasia Manifestation
Journal of Dentistry for Children, 12/07/09